Assessment of Safety of Remdesivir in Covid - 19 Patients with Estimated Glomerular Filtration Rate (eGFR) < 30 ml/min per 1.73 m^2.

Shan WangChristy HuynhShahidul IslamBrian MaloneNaveed MasaniD'Andrea Joseph

Published in: Journal of intensive care medicine (2021)

Our study showed that remdesivir use in renally-impaired patients with eGFR < 30 ml/min is safe. Remdesivir may be considered as a therapeutic option in this population with COVID-19 infection.

Keyphrases

small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
coronavirus disease
sars cov
respiratory syndrome coronavirus